Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Ceribell, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
Di | Ceribell CEO Jane Chao explains why now was the time for its upsized IPO | 1 | FierceBiotech | ||
Di | CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares | 38 | PR Newswire | SUNNYVALE, Calif., Oct. 15, 2024 /PRNewswire/ -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of... ► Artikel lesen | |
Fr | CeriBell, EEG developer, sees stock rally 35% following $180M IPO | 1 | Seeking Alpha | ||
Fr | Ceribell, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
Fr | Neurotech company CeriBell prices $180.3M IPO | 1 | MassDevice | ||
Fr | Seizure diagnostic company CeriBell prices IPO at $17, the high end of the upwardly revised range | 1 | Renaissance Capital | ||
Fr | CeriBell Prices Upsized 10.61M Share IPO at $17/sh | 1 | Investing.com | ||
Fr | CeriBell prices IPO at $17 per share | 2 | Seeking Alpha | ||
Fr | CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering | 84 | PR Newswire | SUNNYVALE, Calif., Oct. 10, 2024 /PRNewswire/ -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of... ► Artikel lesen | |
09.10. | Seizure diagnostic company CeriBell ups shares by 58%, increases range ahead of $175 million IPO | 2 | Renaissance Capital | ||
09.10. | CeriBell, Inc Files for Upsized 10.6M Share IPO at a Higher $16-$17/sh Price Range | 1 | Investing.com | ||
08.10. | Upstream Bio, CeriBell, CAMP4 set terms for proposed IPOs | 1 | Seeking Alpha | ||
08.10. | Ceribell, Inc. - 8-A12B, Registration of securities | 1 | SEC Filings | ||
07.10. | Seizure-spotting headset maker Ceribell seeks $101M Nasdaq IPO | 6 | FierceBiotech | ||
07.10. | Seizure diagnostic company CeriBell sets terms for $101 million IPO | 1 | Renaissance Capital | ||
07.10. | CeriBell, Inc Files for 6.7M Share IPO at $14-$16/sh | 1 | Investing.com | ||
07.10. | Ceribell, Inc. - S-1/A, General form for registration of securities | 2 | SEC Filings | ||
19.09. | Ceribell, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
27.08. | Seizure diagnostic company Ceribell files for a $100 million IPO | 1 | Renaissance Capital |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 33,030 | -1,90 % | Covestro steht vor der Übernahme - Fresenius will weiter organisch wachsen | Die Übernahme des Chemie-Konzerns Covestro soll noch in dieser Woche durchgeführt werden. VAE sichert sich weiteren Zugang zu Deutschlands Wirtschaft. Fresenius kehrt der Übernahmestrategie den Rücken... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 72,42 | 0,00 % | PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer | A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate Cancer Represents Potential Paradigm Shift in... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 11,800 | 0,00 % | What Analysts Are Saying About Alignment Healthcare Stock | ||
PROGYNY | 16,570 | 0,00 % | Progyny, Inc. Announces Second Quarter 2024 Results | Achieves Record Quarterly Adjusted EBITDA, Strong Cash Flow Conversion RateBoard Authorizes Repurchase of $100 Million of Common Stock NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq:... ► Artikel lesen | |
TEMPUS AI | 49,030 | 0,00 % | Cathie Woods ARK ETF konzentriert sich auf Tempus AI und AMD-Aktien | ||
GERRESHEIMER | 84,25 | +1,81 % | Ihre wichtigsten Termine: Gerresheimer, Südzucker und Givaudan legen Q3-Zahlen vor! | © Foto: picture alliance/ASSOCIATED PRESS/Gerresheimer AG - picture alliance/ASSOCIATED PRESS/Gerresheimer AGGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 51,96 | +0,15 % | Siemens Healthineers: Geben Umsatzprognosen für das Geschäftsjahr neue Perspektiven? | Aktie im Fokus, die Aktuelle Analyse am 10.10.2024 | ||
GENEDX | 60,94 | 0,00 % | The Analyst Verdict: GeneDx Holdings In The Eyes Of 6 Experts | ||
CARL ZEISS MEDITEC | 61,20 | -0,08 % | Carl Zeiss Meditec Aktie: Kursrückgang trotz stabiler Prognosen | Die Carl Zeiss Meditec-Aktie verzeichnete am Mittwoch einen deutlichen Rückgang im XETRA-Handel. Bis zum Nachmittag fiel der Kurs um 3,6 Prozent auf 64,85 Euro, nachdem das Papier bei 66,95 Euro in... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 15,850 | 0,00 % | BrightSpring Health announces CLO retirement and transition plan | ||
CASTLE BIOSCIENCES | 33,760 | 0,00 % | Castle Biosciences (NASDAQ:CSTL) Sees Unusually-High Trading Volume Following Analyst Upgrade | ||
RXSIGHT | 50,66 | 0,00 % | RxSight, Inc. (RXST): A Visionary Small-Cap Stock Pick by Hedge Funds | ||
TALKSPACE | 2,825 | 0,00 % | Talkspace Aktie: Führender Platform für Online Therapie von Depression etc. in den USA | In diesem Video präsentiert der Sprecher Talkspace, eine führende Plattform für Online-Therapie, die insbesondere für psychische Erkrankungen wie Depressionen und Beziehungsprobleme entwickelt wurde.... ► Artikel lesen | |
PACS GROUP | 41,910 | 0,00 % | PACS Group, Inc. Reports Second Quarter 2024 Results | FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 18,080 | 0,00 % | KeyCorp Initiates Coverage on Privia Health Group (NASDAQ:PRVA) |